We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$415M
AUM Growth
+$17.2M
Cap. Flow
-$15.8M
Cap. Flow %
-3.8%
Top 10 Hldgs %
43.54%
Holding
60
New
2
Increased
7
Reduced
37
Closed
2

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$5.83M
2
ZBRA icon
Zebra Technologies
ZBRA
+$3.75M
3
ULTA icon
Ulta Beauty
ULTA
+$3.48M
4
KEYS icon
Keysight
KEYS
+$3.06M
5
PEP icon
PepsiCo
PEP
+$2.88M

Sector Composition

Rank Sector Weight
1 Technology 25.17%
2 Healthcare 18.58%
3 Financials 15.29%
4 Consumer Staples 12.54%
5 Consumer Discretionary 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.84T
$30.8M 7.43%
73,325
-1,880
-2% -$761K
PM icon
2
Philip Morris
PM
$301B
$18.9M 4.54%
205,830
-4,678
-2% -$431K
META icon
3
Meta Platforms (Facebook)
META
$1.51T
$18.7M 4.5%
38,462
-4,581
-11% -$2.04M
MSI icon
4
Motorola Solutions
MSI
$69.4B
$17.8M 4.29%
50,131
-1,600
-3% -$527K
UNH icon
5
UnitedHealth
UNH
$382B
$16.7M 4.02%
33,732
+3,735
+12% +$1.9M
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$3.91T
$16.5M 3.98%
109,500
+15,658
+17% +$2.24M
MDT icon
7
Medtronic
MDT
$107B
$16.4M 3.96%
188,571
-4,255
-2% -$363K
ALSN icon
8
Allison Transmission
ALSN
$10.1B
$15M 3.62%
185,313
-6,222
-3% -$419K
FISV
9
Fiserv Inc
FISV
$27.2B
$15M 3.62%
93,926
-3,397
-3% -$495K
AVGO icon
10
Broadcom
AVGO
$1.82T
$14.9M 3.58%
112,300
+40,260
+56% +$4.99M
JNJ icon
11
Johnson & Johnson
JNJ
$634B
$14.5M 3.5%
91,941
-1,790
-2% -$285K
AXP icon
12
American Express
AXP
$223B
$13.7M 3.3%
60,120
-2,070
-3% -$429K
MRSH
13
Marsh
MRSH
$86.3B
$11M 2.66%
53,615
-1,944
-3% -$387K
HSIC icon
14
Henry Schein
HSIC
$9.74B
$10.9M 2.62%
144,102
+71,870
+99% +$5.39M
KVUE icon
15
Kenvue
KVUE
$37B
$10.6M 2.56%
494,776
-10,241
-2% -$208K
MDLZ icon
16
Mondelez International
MDLZ
$77.7B
$9.46M 2.28%
135,183
-1,721
-1% -$126K
BDX icon
17
Becton Dickinson
BDX
$43.1B
$9.12M 2.2%
36,839
-1,171
-3% -$280K
KEYS icon
18
Keysight
KEYS
$54.5B
$8.66M 2.08%
55,349
-19,869
-26% -$3.06M
CSCO icon
19
Cisco
CSCO
$450B
$8.24M 1.99%
165,165
-36,011
-18% -$1.8M
ALLE icon
20
Allegion
ALLE
$13B
$8.1M 1.95%
60,130
+5,318
+10% +$681K
GWW icon
21
W.W. Grainger
GWW
$65.3B
$7.71M 1.86%
7,575
-1,129
-13% -$1.05M
TFC icon
22
Truist Financial
TFC
$63.2B
$7.29M 1.76%
186,986
+48,558
+35% +$1.78M
BKNG icon
23
Booking.com
BKNG
$138B
$7.16M 1.72%
49,350
-8,975
-15% -$1.28M
ROST icon
24
Ross Stores
ROST
$76.6B
$7.03M 1.69%
47,870
-15,373
-24% -$2.2M
BRK.B icon
25
Berkshire Hathaway Class B
BRK.B
$1.07T
$6.86M 1.65%
16,323

Similar funds

Foyston, Gordon, & Payne's Q1 2024 Portfolio in Review

As of Q1 2024, Foyston, Gordon, & Payne held 60 positions worth $415M, up 4.3% from $398M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Foyston, Gordon, & Payne withdrew a net $15.8M in Q1 2024, closing 2 positions and reducing 37 holdings. Its most notable exit was Humana, an estimated $5.83M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Foyston, Gordon, & Payne opened a new position in Eagle Materials worth $254K.

  • Foyston, Gordon, & Payne's largest Q1 2024 buy was Eagle Materials: 933 shares worth $254K.
  • Foyston, Gordon, & Payne added most to Henry Schein in Q1 2024, an estimated $5.39M increase.
  • Foyston, Gordon, & Payne's biggest Q1 2024 reduction was Zebra Technologies, cutting an estimated $3.75M.
  • Foyston, Gordon, & Payne fully exited Humana in Q1 2024, selling an estimated $5.83M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 44% of its $415M portfolio in Q1 2024.
  • Foyston, Gordon, & Payne opened 2 new positions and closed 2 in Q1 2024.
  • Foyston, Gordon, & Payne's portfolio value rose 4.3% quarter-over-quarter to $415M.

Based on Foyston, Gordon, & Payne's 13F filing for Q1 2024, filed 7 May 2024.